Suppr超能文献

糖皮质激素受体:肥胖的成因还是治疗方法?

The glucocorticoid receptor: cause of or cure for obesity?

作者信息

John Kezia, Marino Joseph S, Sanchez Edwin R, Hinds Terry D

机构信息

Center for Hypertension and Personalized Medicine and.

Department of Kinesiology, University of North Carolina Charlotte, Charlotte, North Carolina.

出版信息

Am J Physiol Endocrinol Metab. 2016 Feb 15;310(4):E249-57. doi: 10.1152/ajpendo.00478.2015. Epub 2015 Dec 29.

Abstract

Glucocorticoid hormones (GCs) are important regulators of lipid metabolism, promoting lipolysis with acute treatment but lipogenesis with chronic exposure. Conventional wisdom posits that these disparate outcomes are mediated by the classical glucocorticoid receptor GRα. There is insufficient knowledge of the GC receptors (GRα and GRβ) in metabolic conditions such as obesity and diabetes. We present acute models of GC exposure that induce lipolysis, such as exercise, as well as chronic-excess models that cause obesity and lipid accumulation in the liver, such as hepatic steatosis. Alternative mechanisms are then proposed for the lipogenic actions of GCs, including induction of GC resistance by the GRβ isoform, and promotion of lipogenesis by GC activation of the mineralocorticoid receptor (MR). Finally, the potential involvement of chaperone proteins in the regulation of adipogenesis is considered. This reevaluation may prove useful to future studies on the steroidal basis of adipogenesis and obesity.

摘要

糖皮质激素(GCs)是脂质代谢的重要调节因子,急性治疗时促进脂肪分解,但长期暴露则促进脂肪生成。传统观点认为,这些不同的结果是由经典糖皮质激素受体GRα介导的。在肥胖和糖尿病等代谢状况下,对糖皮质激素受体(GRα和GRβ)的了解不足。我们展示了诱导脂肪分解的GC急性暴露模型,如运动,以及导致肥胖和肝脏脂质积累的慢性过量模型,如肝脂肪变性。然后提出了GC脂肪生成作用的替代机制,包括GRβ亚型诱导GC抵抗,以及GC激活盐皮质激素受体(MR)促进脂肪生成。最后,考虑了伴侣蛋白在脂肪生成调节中的潜在作用。这种重新评估可能对未来关于脂肪生成和肥胖的甾体基础的研究有用。

相似文献

1
The glucocorticoid receptor: cause of or cure for obesity?
Am J Physiol Endocrinol Metab. 2016 Feb 15;310(4):E249-57. doi: 10.1152/ajpendo.00478.2015. Epub 2015 Dec 29.
4
Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways.
Prostaglandins Other Lipid Mediat. 2024 Aug;173:106840. doi: 10.1016/j.prostaglandins.2024.106840. Epub 2024 Jun 1.
6
GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of mA on lipogenic mRNAs.
RNA Biol. 2020 Jul;17(7):930-942. doi: 10.1080/15476286.2020.1736868. Epub 2020 Mar 9.
7
Cortisol resistance in conditions such as asthma and the involvement of 11beta-HSD-2: a hypothesis.
Horm Metab Res. 2006 Jun;38(6):368-76. doi: 10.1055/s-2006-944530.
8
Genomic and Non-Genomic Actions of Glucocorticoids on Adipose Tissue Lipid Metabolism.
Int J Mol Sci. 2021 Aug 7;22(16):8503. doi: 10.3390/ijms22168503.
9
Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
Int J Mol Sci. 2018 Jun 29;19(7):1906. doi: 10.3390/ijms19071906.
10
Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.
Biochem Biophys Res Commun. 2012 Mar 9;419(2):182-7. doi: 10.1016/j.bbrc.2012.01.139. Epub 2012 Feb 3.

引用本文的文献

1
Hallmarks of Cancer Cachexia: Sexual Dimorphism in Related Pathways.
Int J Mol Sci. 2025 Apr 22;26(9):3952. doi: 10.3390/ijms26093952.
2
Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale.
J Health Popul Nutr. 2025 Apr 9;44(1):112. doi: 10.1186/s41043-025-00860-z.
3
Steroid receptors and coregulators: Dissemination of sex differences and emerging technologies.
J Biol Chem. 2025 Apr;301(4):108363. doi: 10.1016/j.jbc.2025.108363. Epub 2025 Feb 27.
6
Circadian-independent light regulation of mammalian metabolism.
Nat Metab. 2024 Jun;6(6):1000-1007. doi: 10.1038/s42255-024-01051-6. Epub 2024 Jun 3.
7
Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways.
Prostaglandins Other Lipid Mediat. 2024 Aug;173:106840. doi: 10.1016/j.prostaglandins.2024.106840. Epub 2024 Jun 1.
8
Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study.
Pediatr Nephrol. 2024 Sep;39(9):2667-2677. doi: 10.1007/s00467-024-06370-0. Epub 2024 Apr 18.
9
Pharmacotherapy causing weight gain and metabolic alteration in those with obesity and obesity-related conditions: A review.
Ann N Y Acad Sci. 2024 Mar;1533(1):145-155. doi: 10.1111/nyas.15112. Epub 2024 Feb 22.

本文引用的文献

2
Transcriptional and metabolic effects of glucocorticoid receptor α and β signaling in zebrafish.
Endocrinology. 2015 May;156(5):1757-69. doi: 10.1210/en.2014-1941. Epub 2015 Mar 10.
4
Decreased adipogenesis and adipose tissue in mice with inactivated protein phosphatase 5.
Biochem J. 2015 Feb 15;466(1):163-76. doi: 10.1042/BJ20140428.
5
Cardiovascular and metabolic impact of glucocorticoid replacement therapy.
Front Horm Res. 2014;43:33-44. doi: 10.1159/000360556. Epub 2014 Jun 10.
6
FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway.
Mol Endocrinol. 2014 Aug;28(8):1254-64. doi: 10.1210/me.2014-1023. Epub 2014 Jun 16.
7
FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ.
Mol Endocrinol. 2014 Aug;28(8):1265-75. doi: 10.1210/me.2014-1022. Epub 2014 Jun 16.
8
Glucocorticoid receptor gene expression in adipose tissue and associated metabolic risk in black and white South African women.
Int J Obes (Lond). 2015 Feb;39(2):303-11. doi: 10.1038/ijo.2014.94. Epub 2014 May 20.
9
Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome.
Steroids. 2014 Dec;91:46-53. doi: 10.1016/j.steroids.2014.05.001. Epub 2014 May 10.
10
Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN.
J Biol Chem. 2014 Jun 20;289(25):17885-94. doi: 10.1074/jbc.M113.544072. Epub 2014 May 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验